As of 18 Sept 2026, Fredun Pharmaceuticals Ltd share price is ₹1,278.65. The stock opened at ₹1,278.65 and had closed at ₹1,221.60 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹390.56 and a high of ₹1,600.00. In terms of performance, Fredun Pharmaceuticals Ltd share price has increased by 126.93% over the past six months and has increased by 198.24% over the last year.
FREDUN Stock Price Chart
Fredun Pharmaceuticals Ltd Overview
About FREDUN
Fredun Pharmaceuticals in its Endeavour to move ahead has now ventured into manufacturing of dietary /herbal supplements, nutraceuticals, and other healthcare products along with Animal Healthcare products also with products ranging from allopathic formulations to on field diagnostic kits, Company’s main aim is to be a holistic healthcare provider.
Fredun Pharmaceuticals Ltd Historical Performance
Fredun Pharmaceuticals Ltd Fundamentals
Fredun Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 639.12 | 456.27 | 349.07 | 276.50 | 226.09 |
| EBITDA | 94.79 | 55.10 | 38.90 | 29.60 | 15.43 |
| Net Profit | 33.21 | 20.81 | 15.62 | 10.81 | 6.34 |
| EPS | 68.01 | 44.83 | 33.32 | 22.93 | 14.29 |
Fredun Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,156.68 |
| Resistance 1 (R1) | 1,323.18 |
| Pivot Point | 1,258.27 |
Fredun Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 23-Jun-2026 | 25-May-2026 | 23-Jun-2026 | Final | ₹0.70 |
| 23-Sep-2025 | 31-May-2025 | 23-Sep-2025 | Final | ₹0.70 |
| 23-Sep-2024 | 07-May-2024 | 23-Sep-2024 | Final | ₹0.70 |
| 22-Sep-2023 | 24-May-2023 | 22-Sep-2023 | Final | ₹0.70 |
| 16-Sep-2021 | 29-Jun-2021 | 18-Sep-2021 | Final | ₹0.70 |
FREDUN Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Daulat N Medhora | Chairman & Managing Director |
| Fredun N Medhora | Managing Director |
| Daisy Dsouza | Non Executive Independent Director |
Fredun Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Fredun Pharmaceuticals Ltd today is ₹1,278.65 on NSE and ₹1,278.65 on BSE.
- The 52-week high of Fredun Pharmaceuticals Ltd is ₹1,600.00, while the 52-week low is ₹390.56.
- The current market capitalisation of Fredun Pharmaceuticals Ltd is approximately ₹2,115 crore.
- The P/E (Price-to-Earnings) ratio of Fredun Pharmaceuticals Ltd is 25.19. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Fredun Pharmaceuticals Ltd is 3.46. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Fredun Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for FREDUN on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Fredun Pharmaceuticals Ltd has delivered a return of approximately 301.10%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Fredun Pharmaceuticals Ltd comprises different categories of shareholders. As of Jul 2026, the shareholding is approximately 44.57% promoters, 1.06% FIIs, 2.94% DIIs, and 43.62% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
